Concepedia

Kafi N. Sanders

KN

Statistics

Publications

10

Citations

766

H-Index

10

Active since

2001

Affiliations

Pfizer (United States)(Current)

University of California, Irvine

New York University

Nathan Kline Institute for Psychiatric Research

Thomson Reuters (United States)

Kafi N. Sanders is an author at Pfizer (United States) specializing in pharmacotherapy, psychopharmacology, and antipsychotic therapy.

Publications per year

2001–2021

10

Publications

10

Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making

Vaibhav Katkade, Kafi N. Sanders, Kelly H. Zou · Journal of Multidisciplinary Healthcare · 2018 · 248 citations · Full text

, , +13

Do gender and race affect decisions about pain management?

Carol S. Weisse, Paul Clay Sorum, Kafi N. Sanders et al. · Journal of General Internal Medicine · 2001 · 231 citations · Full text

, , +11

Findings of a U.S. National Cardiometabolic Screening Program Among 10,084 Psychiatric Outpatients

Christoph U. Correll, Benjamin G. Druss, Ilise Lombardo et al. · Psychiatric Services · 2010 · 113 citations

, , +16

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study

Ariel Berger, John Edelsberg, Kafi N. Sanders et al. · BMC Psychiatry · 2012 · 37 citations · Full text

, , +17

Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder

Leslie Citrome, Christopher Reist, Liisa Palmer et al. · Schizophrenia Research · 2008 · 35 citations

, , +15

1–5 of 10